Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00739310 · ClinicalTrials.gov registry record · NA
Study Assessing High-Frequency Chest Wall Oscillation (HFCWO) in Preventing Pulmonary Exacerbations
A NA study, sponsored by Hill-Rom.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT00739310 is a NA study that has completed, run by Hill-Rom. The registered enrollment target is 29 participants.
The verdict
NCT00739310, a NA study, has completed, sponsored by Hill-Rom.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
To asssess efficacy of airway clearance provided by Vest therapy (HFCWO) in the reduction of respiratory exacerbations requiring hospitalization or antibiotic utilization in patients with muscle weakness and restrictive lung disease.
Interventions
- DEVICE Vest Treatment (high frequency chest wall oscillation)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2008-08 |
| Est. Completion | 2011-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00739310
The ClinicalTrials.gov registry entry for NCT00739310 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hill-Rom, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vest Treatment (high frequency chest wall oscillation) is the first listed.
NCT00739310 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00739310 about?
NCT00739310 is a clinical study titled "Study Assessing High-Frequency Chest Wall Oscillation (HFCWO) in Preventing Pulmonary Exacerbations". To asssess efficacy of airway clearance provided by Vest therapy (HFCWO) in the reduction of respiratory exacerbations requiring hospitalization or antibiotic utilization in patients with muscle weakness and restrictive lung disease.
What is the current status of trial NCT00739310?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2008-08. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00739310?
The interventions under investigation include: Vest Treatment (high frequency chest wall oscillation) (DEVICE).
Who is sponsoring clinical trial NCT00739310?
This trial is sponsored by Hill-Rom, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.